[HTML][HTML] Artificial intelligence in pathology

S Försch, F Klauschen, P Hufnagl… - Deutsches Ärzteblatt …, 2021 - ncbi.nlm.nih.gov
Background Increasing digitalization enables the use of artificial intelligence (AI) and
machine learning in pathology. However, these technologies have only just begun to be …

German S3 guidelines: anal abscess and fistula (second revised version)

A Ommer, A Herold, E Berg, A Fürst, S Post… - … archives of surgery, 2017 - Springer
Background The incidence of anal abscess and fistula is relatively high, and the condition is
most common in young men. Methods This is a revised version of the German S3 guidelines …

Diagnostic and prognostic value of CEA and CA19-9 in colorectal cancer

L Lakemeyer, S Sander, M Wittau, D Henne-Bruns… - Diseases, 2021 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early
stages with enhanced screening methods is vital as metastases and recurrences increase …

[HTML][HTML] Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK …

S Stintzing, P Wirapati, HJ Lenz, D Neureiter… - Annals of …, 2019 - Elsevier
Background FIRE-3 compared first-line therapy with FOLFIRI plus either cetuximab or
bevacizumab in 592 KRAS exon 2 wild-type metastatic colorectal cancer (mCRC) patients …

[HTML][HTML] S3-Leitlinie Magenkarzinom–Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs–Langversion 2.0–August …

M Moehler, SE Al-Batran, T Andus… - Zeitschrift für …, 2019 - thieme-connect.com
In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

[HTML][HTML] Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer

TJ Oh, N Kim, Y Moon, MS Kim, BD Hoehn… - The Journal of Molecular …, 2013 - Elsevier
Aberrant DNA methylation has shown promise as a biomarker for the early detection of
cancer. To discover novel genes frequently methylated at an early stage in colorectal cancer …

Precision medicine for metastatic colorectal cancer in clinical practice

JE Riedesser, MP Ebert… - Therapeutic Advances in …, 2022 - journals.sagepub.com
Globally, metastatic colorectal cancer is one of the leading causes for cancer-related death.
Treatment limited to conventional chemotherapeutics extended life for only a few months …

[HTML][HTML] Endoscopic resection techniques for colorectal neoplasia: Current developments

FL Dumoulin, R Hildenbrand - World Journal of Gastroenterology, 2019 - ncbi.nlm.nih.gov
Endoscopic polypectomy and endoscopic mucosal resection (EMR) are the established
treatment standards for colorectal polyps. Current research aims at the reduction of both …

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III …

TO Götze, P Piso, S Lorenzen, US Bankstahl, C Pauligk… - BMC cancer, 2021 - Springer
Background The main reason for treatment failure after curative surgical resection of gastric
cancer is intra-abdominal spread, with 40–50% peritoneal seeding as primary localization of …

[HTML][HTML] Screening and surveillance in hereditary gastrointestinal cancers: recommendations from the European Society of Digestive Oncology (ESDO) expert …

DB Vangala, E Cauchin, J Balmaña, L Wyrwicz… - European journal of …, 2018 - Elsevier
Patients with hereditary gastrointestinal (GI) cancers represent a substantial fraction of the
overall affected population. Although awareness for hereditary GI cancer syndromes is on …